methyl 2,6-dimethoxy-4-formylbenzoate | 33187-98-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: methyl 2,6-dimethoxy-4-formylbenzoate
• 英文别名: Methyl 4-formyl-2,6-dimethoxybenzoate
• CAS: 33187-98-3
• 化学式: C₁₁H₁₂O₅
• 分子量: 224.213
• InChiKey: DMZKZOINHKXBDE-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.2
• 重原子数：
  16
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.27
• 拓扑面积：
  61.8
• 氢给体数：
  0
• 氢受体数：
  5

反应信息

• 作为反应物：
  描述：

  methyl 2,6-dimethoxy-4-formylbenzoate 在 sodium methylate 、 sodium hydride 作用下， 以 乙醇 、 N,N-二甲基甲酰胺 、 异丙醇 为溶剂， 反应 41.83h， 生成 4'-<(2,4-diamino-5-pyrimidinyl)methyl>-2',6'-dimethoxy-2-methylsulfonyl acetophenone hydrochloride
  参考文献：
  名称：

  Kompis; Then; Boehni, European Journal of Medicinal Chemistry, 1980, vol. 15, # 1, p. 17 - 22

  摘要：

  DOI：
• 作为产物：
  描述：

  3,4,5-三甲氧基苯甲醛二甲基缩醛 在 sodium 、 溶剂黄146 作用下， 以 水 为溶剂， 反应 32.0h， 生成 methyl 2,6-dimethoxy-4-formylbenzoate
  参考文献：
  名称：

  Regioselective reductive electrophilic substitution of derivatives of 3,4,5-trimethoxybenzaldehyde

  摘要：

  The behavior of several protected derivatives of 3,4,5-trimethoxybenzaldehyde has been investigated under conditions of electron transfer from alkali metals in aprotic solvents. The 4-methoxy group can be regioselectively removed in good to high yield under such conditions, and an appropriate choice of the protecting group, metal, and solvent allows its substitution with a variety of electrophiles. 3,4,5-Trimethoxybenzaldehyde dimethyl acetal, 1, is the starting material of choice for a new general synthetic approach to several polysubstituted resorcinol dimethyl ethers. Investigation of the mechanism of demethoxylation, with the aid of labeling experiments, showed that reductive demethoxylation is strongly influenced by the nature of the aldehyde protective group employed.

  DOI：

  10.1021/jo00037a029

文献信息

• [EN] NOVEL DIHYDROPYRIMIDIN-2(1H)-ONE COMPOUNDS AS S-NITROSOGLUTATHIONE REDUCTASE INHIBITORS<br/>[FR] NOUVEAUX COMPOSÉS DIHYDROPYRIMIDINE-2(1H)-ONES EN TANT QU'INHIBITEURS DE LA S-NITROSOGLUTATHION RÉDUCTASE
  申请人：N30 PHARMACEUTICALS LLC

  公开号：WO2011038204A1

  公开（公告）日：2011-03-31

  The present invention is directed to novel dihydropyrimidin-2(1H)-one compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.

  本发明涉及一种新型二氢嘧啶-2(1H)-酮化合物，可用作S-亚硝基谷胱甘肽还原酶（GSNOR）抑制剂，包括这些化合物的药物组合物，以及制备和使用这些化合物的方法。
• 2,4-Diamino-5-benzylpyrimidines
  申请人：Hoffmann-La Roche Inc.

  公开号：US03931181A1

  公开（公告）日：1976-01-06

  2,4-Diamino-5-benzylpyrimidines characterized by the formula ##SPC1## Wherein R.sup.1, R.sup.2, A.sup.1, Z and n are as hereinafter set forth, are described. The 2,4-diamino-5-benzylpyrimidines of the invention have useful antibacterial activity. More particularly, they block bacterial dihydrofolate reductase and potentiate the antibacterial activity of sulfonamides.

  2,4-二氨基-5-苄基嘧啶的化学式为##SPC1##，其中R.sup.1、R.sup.2、A.sup.1、Z和n如下所述。本发明的2,4-二氨基-5-苄基嘧啶具有有用的抗菌活性。更具体地说，它们可以阻断细菌的二氢叶酸还原酶，并增强磺胺类药物的抗菌活性。
• INDENYL COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND MEDICAL USES THEREOF
  申请人：ADT PHARMACEUTICALS, INC.

  公开号：US20160168113A1

  公开（公告）日：2016-06-16

  Disclosed are compounds, for example, compounds of formula I, wherein R, R 0 , R 1 -R 8 , n, X, Y, Y′, and E are as described herein, pharmaceutical compositions containing such compounds, and methods of treating or preventing a disease or condition, for example, cancer.

  揭示了化合物，例如，具有公式I的化合物，其中R、R0、R1-R8、n、X、Y、Y′和E如本文所述，包含这些化合物的药物组合物，以及治疗或预防疾病或病症的方法，例如癌症。
• Novel Dihydropyrimidin-2(1H)-one Compounds as S-Nitrosoglutathione Reductase Inhibitors
  申请人：Sun Xicheng

  公开号：US20120208817A1

  公开（公告）日：2012-08-16

  The present invention is directed to novel dihydropyrimidin-2(1H)-one compounds useful as S-nitrosoglutathione reductase (GSNOR) inhibitors, pharmaceutical compositions comprising such compounds, and methods of making and using the same.

  本发明涉及一种新型二氢嘧啶-2(1H)-酮化合物，其可用作S-亚硝基谷胱甘肽还原酶（GSNOR）抑制剂，包括这种化合物的制药组合物，以及制造和使用它们的方法。
• Indenyl compounds, pharmaceutical compositions, and medical uses thereof
  申请人：ADT Pharmaceuticals, LLC

  公开号：US10975054B2

  公开（公告）日：2021-04-13

  Disclosed are compounds, for example, compounds of formula I, wherein R, R0, R1-R8, n, X, Y, Y′, and E are as described herein, pharmaceutical compositions containing such compounds, and methods of treating or preventing a disease or condition, for example, cancer.

  公开了一些化合物，例如式 I 的化合物、 其中 R、R0、R1-R8、n、X、Y、Y′ 和 E 如本文所述；含有此类化合物的药物组合物；以及治疗或预防疾病或病症（例如癌症）的方法。